ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $119,000 | +11800.0% | 2,244 | +5510.0% | 0.00% | – |
| Q2 2020 | $1,000 | -97.6% | 40 | -95.6% | 0.00% | -100.0% |
| Q4 2015 | $42,000 | -16.0% | 909 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $50,000 | +2.0% | 909 | +1236.8% | 0.00% | 0.0% |
| Q2 2015 | $49,000 | +25.6% | 68 | -37.0% | 0.00% | 0.0% |
| Q1 2015 | $39,000 | +18.2% | 108 | -22.9% | 0.00% | – |
| Q3 2014 | $33,000 | -93.1% | 140 | -99.3% | 0.00% | -100.0% |
| Q4 2013 | $478,000 | +102.5% | 18,720 | +117.7% | 0.01% | +80.0% |
| Q3 2013 | $236,000 | +108.8% | 8,600 | +67.0% | 0.01% | +66.7% |
| Q2 2013 | $113,000 | – | 5,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |